Sinoma Science & TechnologyLtd Past Earnings Performance
Past criteria checks 1/6
Sinoma Science & TechnologyLtd has been growing earnings at an average annual rate of 16.8%, while the Chemicals industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 16.2% per year. Sinoma Science & TechnologyLtd's return on equity is 9.3%, and it has net margins of 8%.
Key information
16.8%
Earnings growth rate
16.8%
EPS growth rate
Chemicals Industry Growth | 12.1% |
Revenue growth rate | 16.2% |
Return on equity | 9.3% |
Net Margin | 8.0% |
Next Earnings Update | 22 Aug 2024 |
Recent past performance updates
Recent updates
These 4 Measures Indicate That Sinoma Science & TechnologyLtd (SZSE:002080) Is Using Debt Extensively
Jul 25Why Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Could Be Worth Watching
Jun 10Sinoma Science & TechnologyLtd (SZSE:002080) Has Announced That Its Dividend Will Be Reduced To CN¥0.56
May 27Capital Allocation Trends At Sinoma Science & TechnologyLtd (SZSE:002080) Aren't Ideal
May 13Are Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Investors Paying Above The Intrinsic Value?
Apr 14Earnings Troubles May Signal Larger Issues for Sinoma Science & TechnologyLtd (SZSE:002080) Shareholders
Mar 31Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Price Is Right But Growth Is Lacking
Mar 14Should You Think About Buying Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Now?
Feb 28Revenue & Expenses Breakdown
How Sinoma Science & TechnologyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 25,276 | 2,027 | 1,808 | 1,242 |
31 Dec 23 | 25,889 | 2,224 | 1,802 | 1,299 |
30 Sep 23 | 27,025 | 2,832 | 1,730 | 1,353 |
30 Jun 23 | 27,546 | 3,075 | 1,703 | 1,294 |
31 Mar 23 | 26,196 | 3,253 | 1,578 | 1,262 |
01 Jan 23 | 25,814 | 3,574 | 1,503 | 1,209 |
30 Sep 22 | 23,462 | 3,172 | 1,507 | 1,060 |
30 Jun 22 | 22,372 | 3,413 | 1,381 | 988 |
31 Mar 22 | 20,934 | 3,518 | 1,286 | 940 |
31 Dec 21 | 20,295 | 3,373 | 1,260 | 961 |
30 Sep 21 | 20,522 | 3,159 | 1,187 | 1,065 |
30 Jun 21 | 20,600 | 2,977 | 1,198 | 1,113 |
31 Mar 21 | 19,999 | 2,387 | 1,232 | 1,075 |
31 Dec 20 | 18,865 | 2,040 | 1,189 | 973 |
30 Sep 20 | 17,038 | 1,889 | 785 | 850 |
30 Jun 20 | 15,148 | 1,634 | 870 | 653 |
31 Mar 20 | 13,821 | 1,405 | 863 | 552 |
31 Dec 19 | 13,590 | 1,380 | 968 | 515 |
30 Sep 19 | 13,148 | 1,167 | 1,353 | 358 |
30 Jun 19 | 12,732 | 1,165 | 1,213 | 358 |
31 Mar 19 | 11,985 | 962 | 1,212 | 357 |
31 Dec 18 | 11,411 | 894 | 1,151 | 356 |
30 Sep 18 | 10,807 | 913 | 1,082 | 392 |
30 Jun 18 | 10,504 | 778 | 961 | 540 |
31 Mar 18 | 10,289 | 778 | 1,032 | 439 |
31 Dec 17 | 10,237 | 767 | 1,086 | 348 |
30 Sep 17 | 9,695 | 699 | 1,166 | 222 |
30 Jun 17 | 9,386 | 539 | 1,441 | 0 |
31 Mar 17 | 9,205 | 499 | 1,355 | 0 |
31 Dec 16 | 8,700 | 438 | 1,338 | 0 |
30 Sep 16 | 8,785 | 436 | 1,337 | 0 |
30 Jun 16 | 8,813 | 568 | 1,331 | 0 |
31 Mar 16 | 9,728 | 678 | 1,386 | 0 |
31 Dec 15 | 9,176 | 630 | 1,247 | 0 |
30 Sep 15 | 8,216 | 613 | 1,025 | 0 |
30 Jun 15 | 6,989 | 451 | 826 | 0 |
31 Mar 15 | 4,837 | 194 | 665 | 0 |
31 Dec 14 | 4,424 | 152 | 649 | 0 |
30 Sep 14 | 3,981 | 108 | 622 | 0 |
30 Jun 14 | 3,680 | 92 | 593 | 0 |
31 Mar 14 | 3,545 | 96 | 582 | 0 |
31 Dec 13 | 3,443 | 108 | 567 | 0 |
30 Sep 13 | 3,243 | 120 | 615 | 0 |
Quality Earnings: 002080 has a large one-off gain of CN¥753.0M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: 002080's current net profit margins (8%) are lower than last year (12.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002080's earnings have grown by 16.8% per year over the past 5 years.
Accelerating Growth: 002080's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 002080 had negative earnings growth (-37.7%) over the past year, making it difficult to compare to the Chemicals industry average (-14.8%).
Return on Equity
High ROE: 002080's Return on Equity (9.3%) is considered low.